Functional Brain Imaging Reveals Rapid Blockade of Abdominal Pain Response Upon Anti-TNF Therapy in Crohn's Disease.
Institute for Pharmacology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Andreas
A
Hess
Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Julie
J
Roesch
Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Marc
M
Saake
Institute for Pharmacology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Marina
M
Sergeeva
Medical Clinic 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Simon
S
Hirschmann
Medical Clinic 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Helmut
H
Neumann
Department of Neuroradiology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Arnd
A
Dörfler
Medical Clinic 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Markus Friedrich
MF
Neurath
Medical Clinic 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany. Electronic address: raja.atreya@uk-erlangen.de.
Raja
R
Atreya
D015746:Abdominal Pain / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology / Q000523:psychology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001688:Biological Products / Q000627:therapeutic use*; D001921:Brain / Q000187:drug effects* / Q000503:physiopathology; D003424:Crohn Disease / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology / Q000523:psychology; D059907:Functional Neuroimaging / Q000379:methods*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab / Q000627:therapeutic use*; D008279:Magnetic Resonance Imaging; D010147:Pain Measurement; D058748:Pain Perception / Q000187:drug effects; D011237:Predictive Value of Tests; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D001688:Biological Products; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab